Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-22-061404
Filing Date
2022-05-16
Accepted
2022-05-16 16:42:03
Documents
81
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ards-20220331x10q.htm   iXBRL 10-Q 1108089
2 EXHIBIT 31.1 ards-20220331xex31d1.htm EX-31.1 10578
3 EXHIBIT 31.2 ards-20220331xex31d2.htm EX-31.2 10563
4 EXHIBIT 32.1 ards-20220331xex32d1.htm EX-32.1 5715
5 EXHIBIT 32.2 ards-20220331xex32d2.htm EX-32.2 5613
  Complete submission text file 0001104659-22-061404.txt   6262743

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ards-20220331.xsd EX-101.SCH 67437
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ards-20220331_cal.xml EX-101.CAL 51916
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ards-20220331_def.xml EX-101.DEF 236160
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ards-20220331_lab.xml EX-101.LAB 508368
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ards-20220331_pre.xml EX-101.PRE 418554
75 EXTRACTED XBRL INSTANCE DOCUMENT ards-20220331x10q_htm.xml XML 850519
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

EIN.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38630 | Film No.: 22930148
SIC: 2834 Pharmaceutical Preparations